TY - JOUR AU - Hattori, Sachiko AU - Nomoto, Kazuomi AU - Suzuki, Tomohiko AU - Hayashi, Seishu PY - 2021 DA - 2021/03/10 TI - Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis JO - Diabetology & Metabolic Syndrome SP - 28 VL - 13 IS - 1 AB - Dipeptidyl peptidase 4 (DPP4) is a serine exopeptidase able to inactivate various oligopeptides, and also a hepatokine. Hepatocyte-specific overexpression of DPP4 is associated with hepatic insulin resistance and liver steatosis. SN - 1758-5996 UR - https://doi.org/10.1186/s13098-021-00644-5 DO - 10.1186/s13098-021-00644-5 ID - Hattori2021 ER -